Post-COVID-19 Painless Thyroiditis: A Case Study on Thyrotoxicosis Management

新冠肺炎后无痛性甲状腺炎:甲状腺毒症管理病例研究

阅读:1

Abstract

BACKGROUND Painless thyroiditis is a rare variant of thyroiditis characterized by low thyroid-stimulating hormone (TSH) levels and normal or elevated T4 concentrations, without clinical signs of acute inflammation. While thyroiditis, including subacute and atypical forms, has been associated with many viral infections including SARS-CoV-2, the occurrence of painless thyroiditis after acute COVID-19 remains uncommon. CASE REPORT We describe the case of a 67-year-old man with history of hypertension, diabetes, and myocardial infarction who presented with a 4-week history of decreased appetite, nausea, weight loss, and upper-extremity tremors. He reported having a resolved case of COVID-19 2 months previously. Laboratory evaluation revealed a low TSH level (0.01 mIU/L) and elevated free T4 (>7.7 µg/dL), with negative thyroid-stimulating and thyroid peroxidase antibodies. A neck ultrasound showed a normal thyroid gland. The patient was diagnosed with post-COVID-19 painless thyroiditis and managed with beta blockers, methimazole, and corticosteroids. His symptoms improved significantly during hospitalization, and he was discharged with follow-up plans to monitor for potential hypothyroidism. CONCLUSIONS This case highlights the importance of considering post-COVID-19 painless thyroiditis in patients presenting with thyrotoxicosis and a history of COVID-19. Prompt recognition and treatment with beta blockers, anti-thyroid drugs, and corticosteroids can lead to symptom resolution. Regular follow-up is crucial to detect and manage potential long-term thyroid dysfunction.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。